Shinichiro Shinzaki

Professor and Chair

Hyogo medical university

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Collaborators (5)

Toshiyuki Sato

Assistant Professor

Hyogo medical university

Yuriko Otake

Osaka University

Kenji Watanabe

University of Toyama

Hiroto Miwa

Hyogo medical university

Katsuyoshi Matsuoka

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shinichiro Shinzaki

Research Interests

Explore related searches

Contact this professor

Articles (10)

Collaborators (5)

Toshiyuki Sato

Yuriko Otake

Kenji Watanabe

Hiroto Miwa

Katsuyoshi Matsuoka

Make your next move.

Shinichiro Shinzaki

Research Interests

Explore related searches

Contact this professor

Articles (10)

Antidiabetic drugs for IBD: a long but promising road ahead for drug repositioning to target intestinal inflammation.

Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn’s Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn’s Disease (iCREST-CD)

Safety and Effectiveness of Vedolizumab in Patients with Moderate-to-Severe Ulcerative Colitis: An Interim Analysis of a Japanese Post-Marketing Surveillance Study

Effect of Bifidobacterium bifidum G9-1 on the Intestinal Environment and Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)-like Symptoms in Patients with Quiescent Crohn’s Disease: A Prospective Pilot Study

Combination therapy of ustekinumab and immunomodulator for inflammatory bowel disease: concerns about the different results observed between two meta‐analyses

Lysophosphatidylserines derived from microbiota in Crohn’s disease elicit pathological Th1 response

Efficacy of Serotonin Type 3 Receptor Antagonist Ramosetron on Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)-Like Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Double-Blind, Placebo-Controlled Trial

Nurse-Provided Medication Guidance for Improving Drug Adherence to Thiopurines in Outpatients With Inflammatory Bowel Disease: A Single-Center Prospective Study

Clinical and Histopathological Features of the Differentiated Type of Early Gastric Cancer with an Unclear Lateral Demarcation

Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study

Collaborators (5)

Toshiyuki Sato

Yuriko Otake

Kenji Watanabe

Hiroto Miwa

Katsuyoshi Matsuoka

Make your next move.